U.S. Oil and Gas Stock News

If you are wondering whether NIO at about US$4.89 is a bargain or a value trap, you are not alone. This breakdown is here to unpack that question in more detail. The share price has moved 8.2% over the last week and 5.4% over the last 30 days, while the year to date return is a 4.9% decline and the 1 year return sits at 12.9%. This compares with much weaker 3 year and 5 year returns of 52.6% and 91.8% declines respectively. Recent coverage of NIO has focused on its position in the electric...

If you are wondering whether Jumia Technologies is still attractively priced after its recent volatility, you are not alone. This article will walk through what the current market price might be implying. The stock last closed at US$12.27, with returns of 195.7% over 1 year and 225.5% over 3 years, alongside shorter term moves of a 0.7% decline over 7 days, a 14.0% decline over 30 days, and a 4.4% decline year to date. These mixed returns, strong over several years but weaker in the near...

PowerFleet (AIOT) has just posted its latest numbers, with Q2 2026 revenue at US$111.7 million and a basic EPS loss of US$0.03, setting the stage for how you read the new Q3 2026 update. Over recent periods the company has seen revenue move from US$75.4 million and an EPS loss of US$0.21 in Q1 2025 to US$106.4 million with an EPS loss of US$0.11 in Q3 2025, then to US$103.6 million and an EPS loss of US$0.09 in Q4 2025, and US$104.1 million with an EPS loss of US$0.08 in Q1 2026. With the...

Why Maze Therapeutics (MAZE) Is On Investors’ Radar Maze Therapeutics (MAZE) has drawn fresh attention after recent trading, with the stock closing at $47.71 and showing strong trailing returns over the past year. This performance has prompted investors to reassess its clinical stage profile. See our latest analysis for Maze Therapeutics. The recent 5.95% 1 day share price return, on top of a 47.89% 90 day share price return and a very large 1 year total shareholder return of about 7x,...

Motorcar Parts of America (MPAA) has put out its latest quarterly scorecard, with Q2 2026 revenue at US$221.47 million and basic EPS of a US$0.11 loss, alongside trailing twelve month revenue of US$789.12 million and basic EPS of US$0.13. Over the past few reported periods, the company has seen revenue move from US$169.89 million in Q1 2025 to US$208.19 million in Q2 2025, US$186.18 million in Q3 2025, US$193.11 million in Q4 2025, US$188.36 million in Q1 2026, and US$221.47 million in Q2...

Sohu.com (SOHU) just posted its FY 2025 third quarter numbers, with revenue of US$180.2 million, basic EPS of US$0.32 and net income excluding extra items of US$8.7 million setting the tone for the latest update. The company has seen revenue move from US$151.9 million in Q3 2024 to US$180.2 million in Q3 2025, while basic EPS shifted from a loss of US$0.52 to a profit of US$0.32. This gives investors a cleaner read on how margins are shaping up after a volatile run of results. See our full...

Cleveland Cliffs (CLF) just posted its FY 2025 numbers with Q3 revenue of US$4.7b and a basic EPS loss of US$0.50, alongside trailing twelve month revenue of US$18.6b and a basic EPS loss of US$3.40. Over recent quarters the company has seen revenue move between US$4.3b and US$5.2b while basic EPS has ranged from a small loss of roughly US$0.00 to a loss of US$1.00 per quarter, setting a mixed backdrop for how you read this latest print. With the shares at US$12.31, investors are likely to...

Dynatrace (DT) just posted its Q3 2026 scorecard with recent quarterly revenue running at about $493.8 million and Basic EPS of roughly $0.19, set against a trailing 12 month picture that includes Basic EPS of $1.69 and revenue of about $1.9 billion, plus earnings growth in the dataset of 210.1% over the past year. The company has seen revenue move from $399.2 million in Q1 2025 to $493.8 million in Q2 2026 and quarterly Basic EPS shift from $0.13 to $0.19 over the same period. Year long...

Waters (WAT) FY 2025 earnings snapshot Waters (WAT) reported Q3 FY 2025 revenue of US$799.9 million and basic EPS of US$2.50, with trailing 12 month EPS of US$10.91 on revenue of about US$3.1 billion. The company’s quarterly revenue rose from US$708.5 million in Q2 2024 to US$771.3 million in Q2 2025, and then to US$799.9 million in Q3 2025. Over the same periods, basic EPS moved from US$2.41 to US$2.47 and then to US$2.50, highlighting a story focused on consistent earnings and resilient...

In early February 2026, Exact Sciences reported that its Oncotype DX Breast Recurrence Score test has now guided treatment decisions for more than two million early-stage HR+, HER2- breast cancer patients worldwide, supported by over two decades of clinical evidence and broad global adoption. The company highlighted that Oncotype DX remains the only genomic assay proven to be both prognostic and predictive for chemotherapy benefit, with published models suggesting meaningful lifetime cost...

Sonic Automotive, Inc.'s ( NYSE:SAH ) price-to-earnings (or "P/E") ratio of 16.4x might make it look like a buy right...

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...

Why Ribbon Communications is back on investor radar Ribbon Communications (RBBN) has drawn attention after reporting fourth quarter and full year 2025 results alongside fresh 2026 revenue guidance, giving investors updated numbers on profitability and the coming year. The company reported fourth quarter 2025 revenue of US$227.32 million compared with US$251.36 million a year earlier, while net income moved to US$89.07 million from US$6.36 million. Full year revenue was US$844.56 million...

Earnings event puts Regal Rexnord in focus Regal Rexnord (RRX) is back on investors’ radar after its latest quarterly earnings, where higher adjusted earnings, net income, and operating margins coincided with strong demand in data center, automation, and aerospace markets. See our latest analysis for Regal Rexnord. The earnings news has gone hand in hand with a sharp re-rating in the share price, with a 1-day share price return of 5.9%, a 30-day share price return of 38.8%, and a 1-year total...

Helmerich & Payne (NYSE:HP) recently reduced its term loan by US$260 million ahead of schedule. The company reported strong free cash flow while covering rig reactivation costs in international markets. Dividends were maintained even as the rig market has been soft. For you as an investor, this mix of debt reduction and steady cash generation is a notable development. Helmerich & Payne is a contract driller focused on providing rigs and related services to energy producers, a segment that...

Readers hoping to buy Magyar Bancorp, Inc. ( NASDAQ:MGYR ) for its dividend will need to make their move shortly, as...

Investors were disappointed by Coffee Holding Co., Inc.'s ( NASDAQ:JVA ) latest earnings release. Our analysis has...

Cerence Inc. ( NASDAQ:CRNC ) shareholders won't be pleased to see that the share price has had a very rough month...

Investors in Embecta Corp. ( NASDAQ:EMBC ) had a good week, as its shares rose 2.4% to close at US$10.87 following the...

Stryker Corporation's ( NYSE:SYK ) recent earnings report didn't offer any surprises, with the shares unchanged over...

If you are wondering whether Bio-Techne is attractively priced or just fairly valued right now, you are in the right place to put some structure around that question. Bio-Techne's share price last closed at US$66.78, with returns of 2.3% over 7 days, 1.6% over 30 days, 12.0% year to date, but a 3.9% decline over 1 year, a 12.2% decline over 3 years and a 31.7% decline over 5 years. Recent attention on the stock has been shaped by ongoing interest in life sciences tools companies and how...

The board of Universal Corporation ( NYSE:UVV ) has announced that it will pay a dividend on the 4th of May, with...

Pagaya Technologies Ltd. ( NASDAQ:PGY ) shareholders that were waiting for something to happen have been dealt a blow...

As the United States stock market kicks off February with a strong surge, evidenced by the Dow Jones Industrial Average's 515-point gain and the S&P 500 nearing record highs, investors are keenly observing which stocks could be undervalued amidst this positive momentum. In such an environment, identifying stocks that may be priced below their intrinsic value can present opportunities for investors looking to capitalize on potential growth while navigating current economic developments.